A team of researchers from Roche, including scientists from Roche Pharma Research and Early Development and Roche NimbleGen, reported in Genome Research that they have generated the first draft genome sequence of the cynomolgus monkey (Macaca fascicularis) and developed a novel microarray d ... more
SynenTec To Take Over Roche Cellavista System
Roche and SynenTec announced that Roche will transfer its Cellavista business to SynenTec, the German company which is the original inventor of the Cellavista System. This agreement was made as a result of the Roche Applied Science decision to focus its business, and guarantees future optimal support and development of the technology for its customers.
The Cellavista Imaging System for noninvasively measuring cell expansion uses brightfield and fluorescence detection with multiwell plates, chamber slides or RoboFlasks, for a broad range of cellular applications in cell line development, cellular research and drug discovery.
“It is very important that we ensure uninterrupted support for our customers. We have found the ideal match in SynenTec”, said Dan Zabrowski, Head of Roche Applied Science.
“This acquisition adds significant value for Cellavista customers by enabling them to directly discuss their requirements and needs with the developer of the system,” says Matthias Pirsch, CEO of SynenTec.
Over the last years, SynenTec collaborated with Roche in cell imaging, and was closely involved in the development, service and support of Cellavista Systems. With the business transfer SynenTec will take on worldwide distribution of Cellavista Systems, as well as providing application support and service. Roche will remain the primary contact partner for all support needs for Cellavista Systems delivered by Roche or Innovatis over a transition phase until SynenTec assumes full responsibility on June 01, 2013.
- cell analysis
The xCELLigence RTCA System of Roche is being used in the European Union’s DETECTIVE ("Detection of endpoints and biomarkers for repeated dose toxicity using in vitro systems”) Project, a joint study funded by the European Cosmetics Association (Colipa) and the European Commission, where Ro ... more
The deadly E. coli O104 strain that has killed dozens and hospitalized thousands across Europe has been sequenced using 454 Life Sciences’ benchtop GS Junior sequencing system to generate the “most accurate and detailed genetic analysis to date” of this particularly virulent strain. The seq ... more
- A chemical criterion for rating movies
- SOPAT GmbH and Malvern Panalytical announce a distribution agreement for US market
- Raman spectroscopy allows fast analysis of vaccines
- First experiments at Europe's new X-ray laser reveal unknown structure of antibiotics killer
- New insights into the structure of a killer protein